scholarly journals Barriers to participate in support groups for people living with HIV: A qualitative study with men receiving antiretroviral treatment in a HIV clinic in Mthatha, South Africa

2012 ◽  
Vol 4 (6) ◽  
Author(s):  
Sphiwe Madiba ◽  
Vuyokazi Canti-Sigaqa
2021 ◽  
Vol 20 (1) ◽  
pp. 32-41
Author(s):  
Constance Mubekapi-Musadaidzwa ◽  
Dillon Wademan ◽  
Neshaan Peton ◽  
Portia Hendricks ◽  
Gabriela Carolus ◽  
...  

2016 ◽  
Vol 1 (1) ◽  
pp. 3-16 ◽  
Author(s):  
Philippe Denis ◽  
Molly Longwe ◽  
Ntokozo Zitha

The paper describes the experience of people living with HIV in KwaZulu-Natal. It is based on oral history interviews with members of two support groups in the Pietermaritzburg area that were conducted in 2009 and 2011, respectively. The interviews show that, if stigma and discrimination remain a key component of the experience of people living with HIV in KwaZulu-Natal, certain evolutions are taking place. Nearly all the  nterviewees were on antiretroviral treatment and their health conditions had improved. They deeply appreciated the solidarity they found in their support groups. In most cases their families, friends and neighbours responded positively when they disclosed their status. Yes, obstacles remained. The interviewees, most of whom were women, saw gender stereotypes and men’s resistance to testing, treatment and care as one of their biggest challenges.


2018 ◽  
Vol 22 (8) ◽  
pp. 2543-2552 ◽  
Author(s):  
Valerie A. Earnshaw ◽  
Laura M. Bogart ◽  
Ingrid Courtney ◽  
Holly Zanoni ◽  
David R. Bangsberg ◽  
...  

Author(s):  
Ivo N. Azia ◽  
Ferdinand C. Mukumbang ◽  
Brian Van Wyk

Background: South Africa currently runs the largest public antiretroviral treatment (ART) programme in the world, with over 80% of people living with HIV and/or AIDS on ART. However, in order to appreciate the benefits of using ART, patients are subject to uncompromising and long-term commitments of taking at least 95% of their treatment as prescribed. Evidence shows that this level of adherence is seldom achieved because of a multilevel and sometimes interwoven myriad of factors.Objective: We described the challenges faced by patients on ART in Vredenburg with regard to ART adherence.Methods: A descriptive qualitative research design was used. Eighteen non-adhering patients on ART in the Vredenburg regional hospital were purposefully selected. Using a semistructured interview guide, we conducted in-depth interviews with the study participants in their mother tongue (Afrikaans). The interviews were audio-taped, transcribed verbatim and translated into English. The data were analysed manually using the thematic content analysis method.Results: Stigma, disclosure, unemployment, lack of transport, insufficient feeding, disability grants and alternative forms of therapy were identified as major barriers to adherence, whereas inadequate follow-ups and lack of patient confidentiality came under major criticisms from the patients.Conclusion: Interventions to address poverty, stigma, discrimination and disclosure should be integrated with group-based ART adherence models in Vredenburg while further quantitative investigations should be carried out to quantify the extent to which these factors impede adherence in the community.


2020 ◽  
Vol 18 (5) ◽  
pp. 373-380 ◽  
Author(s):  
SeyedAhmad SeyedAlinaghi ◽  
Maryam Ghadimi ◽  
Mahboubeh Hajiabdolbaghi ◽  
Mehrnaz Rasoolinejad ◽  
Ladan Abbasian ◽  
...  

Background: COVID-19 has spread globally with remarkable speed, and currently, there is limited data available exploring any aspect of the intersection between HIV and SARSCoV- 2 co-infection. Objective: To estimate the prevalence of clinical symptoms associated with COVID-19 among people living with HIV (PLWH) in Tehran, Iran. Design: Cross-sectional study. Methods: A total of 200 PLWH were recruited through the positive club via sampling, and completed the symptom-based questionnaire for COVID-19, which was delivered by trained peers. Results: Of 200 participants, respiratory symptoms, including cough, sputum, and shortness of breath, were the most prevalent among participants, but only one person developed symptoms collectively suggested COVID-19 and sought treatments. Conclusions: It appears that existing infection with HIV or receiving antiretroviral treatment (ART) might reduce the susceptibility to the infection with SARS-CoV-2 or decrease the severity of the infection acquired. Further research is needed to understand causal mechanisms.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Marwân-al-Qays Bousmah ◽  
Marie Libérée Nishimwe ◽  
Christopher Kuaban ◽  
Sylvie Boyer

Abstract Background To foster access to care and reduce the burden of health expenditures on people living with HIV (PLHIV), several sub-Saharan African countries, including Cameroon, have adopted a policy of removing HIV-related fees, especially for antiretroviral treatment (ART). We investigate the impact of Cameroon’s free antiretroviral treatment (ART) policy, enacted in May 2007, on catastrophic health expenditure (CHE) risk according to socioeconomic status, in PLHIV enrolled in the country’s treatment access program. Methods Based on primary data from two cross-sectional surveys of PLHIV outpatients in 2006–2007 and 2014 (i.e., before and after the policy’s implementation, respectively), we used inverse propensity score weighting to reduce covariate imbalances between participants in both surveys, combined with probit regressions of CHE incidence. The analysis included participants treated with ART in one of the 11 HIV services common to both surveys (n = 1275). Results The free ART policy was associated with a significantly lower risk of CHE only in the poorest PLHIV while no significant effect was found in lower-middle or upper socioeconomic status PLHIV. Unexpectedly, the risk of CHE was higher in those with middle socioeconomic status after the policy’s implementation. Conclusions Our findings suggest that Cameroon’s free ART policy is pro-poor. As it only benefitted PLHIV with the lowest socioeconomic status, increased comprehensive HIV care coverage is needed to substantially reduce the risk of CHE and the associated risk of impoverishment for all PLHIV.


Sign in / Sign up

Export Citation Format

Share Document